Tarsus Pharmaceuticals, Inc. has grown revenue 265% a year over three years and 61% a year over five. Revenue growth, 3-year annual rate: +265% (Biotechnology median +21%). Revenue growth, 5-year rate: +61%, growth has picked up over the last three years. Years of annual history on file: 8, FY2018 to FY2025, as filed.

TARSTarsus Pharmaceuticals, Inc.

HealthcareUSD

$70.61

$47.8552 weeks$82.51

Is it growing?

Is TARS growing?

Tarsus Pharmaceuticals, Inc. has grown revenue 265% a year over three years and 61% a year over five.

+265%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +61%
Revenue growth, 5-year rate · +265% over three · growth has picked up over the last three years
Years of annual history on file: 8
Years of annual history on file · FY2018 to FY2025, as filed

Details›